HOME >> BIOLOGY >> NEWS
Top experts and scientists at BioFinland 05 Congress

The congress with its theme Genomic Drug Discovery will approach the entire drug discovery chain from bench to bedside. Identification of targets, validation, and clinical trials are dramatically changing as a consequence of powerful genomics tools being applied in all these areas.

The congress speakers come both from the industry and academia, and they are among others Nobel Laureate (1993) Richard J. Roberts (USA), Leif Groop (Sweden), David R. Cox (USA), Peter Shaw (USA), Kari Alitalo (Finland), Robert G. Pietrusko (USA) and Ruth March (UK).

BioFinland 05 will be held at the Helsinki Fair Centre, April 26 - 27, 2005. The organizers of the congress are Finnish Bioindustries, SITRA (the Finnish National Fund for Research and Development) and Tekes (the Finnish National Technology Agency) as well as the Finnish Fair Corporation.

At the same time, an Investor Forum will be arranged for investors and companies in the bioindustry. Furthermore, there will be ChemBio Finland 05 Exhibition , which will highlight latest innovations and developments within chemical and biotechnology as well as laboratory analytics.

Reduced registration fee until February 28.

For more information on the BioFinland 05 Congress and the speakers: www.biofinland.fi


'"/>

Contact: Ms Saara Hassinen, Assistant Director, Finnish Bioindustries
saara.hassinen@finbio.net
358-917-284-308
Consulate General of Finland
21-Feb-2005


Page: 1

Related biology news :

1. UC experts detail new standard for cleaner transportation fuels
2. Desertification: UN experts prescribe global policy overhaul to avoid looming mass migrations
3. Human ancestors learned to walk upright in the trees, say experts
4. Antarctic lake experts to gather June 6, 7 in Montana
5. Renowned nutrition experts tackle nations obesity problem in new book on primary care nutrition
6. Leading drug discovery and biotechnology scientists and experts discuss latest advancements
7. ALTRAN: Industry experts address technology challenges at Altran Innovation Conference
8. Detaining patients is justified to contain deadly TB strain in South Africa say experts
9. Genetic experts investigate causes of harmful metabolic disorder
10. Specter of possible harm threatens nanotech development, experts say
11. UF experts: Decaffeinated coffee is not caffeine-free

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/21/2016)... , June 21, 2016 NuData Security announced ... new role of principal product architect and that ... director of customer development. Both will report directly ... officer. The moves reflect NuData,s strategic growth in ... to high customer demand and customer focus values. ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a ... take place between the two entities said Poloz. ... Ottawa , he pointed to the country,s ... the federal government. ... said, "Both institutions have common economic goals, why not sit ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
Cached News: